$250 Million is the total value of Blue Edge Capital, LLC's 86 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMCSA | Exit | Comcast Corp New Cl A | $0 | – | -25,900 | -100.0% | -0.36% | – |
| AIG | Exit | American Intl Group | $0 | – | -17,665 | -100.0% | -0.39% | – |
| CELG | Exit | Celgene Corp. | $0 | – | -12,753 | -100.0% | -0.46% | – |
| EUFN | Exit | Ishares Msci Europe | $0 | – | -67,961 | -100.0% | -0.63% | – |
| AET | Exit | Aetna Inc New | $0 | – | -10,098 | -100.0% | -0.69% | – |
| MMM | Exit | 3M Co | $0 | – | -8,075 | -100.0% | -0.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Vanguard Growth | 40 | Q3 2023 | 10.6% |
| Vanguard Value | 40 | Q3 2023 | 10.4% |
| Vanguard European | 40 | Q3 2023 | 9.2% |
| Vanguard FTSE Pacific | 40 | Q3 2023 | 5.9% |
| iShares S&P Midcap 400 Value | 40 | Q3 2023 | 4.8% |
| iShares S&P Midcap 400 Growth | 40 | Q3 2023 | 3.4% |
| SPDR S&P 500 | 40 | Q3 2023 | 2.7% |
| Unitedhealth Group Inc | 40 | Q3 2023 | 2.0% |
| iShares Barclays MBS Bond | 40 | Q3 2023 | 2.1% |
| Exxon Mobil Corp | 40 | Q3 2023 | 2.4% |
View Blue Edge Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-21 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Blue Edge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.